血液系统疾病中的带状疱疹：发病机制、风险分层和预防及免疫接种的新兴策略

Herpes Zoster in Hematological Disorders: Pathogenesis, Risk Stratification, and Emerging Strategies for Prevention and Immunization.

血液系统疾病患者尤其易患 HZ。

造血细胞移植受者中 ChAdOx1-S（AZD1222）疫苗接种后 SARS-CoV-2 中和抗体应答的保留优于 mRNA 疫苗

Greater preservation of SARS-CoV-2 neutralising antibody responses following the ChAdOx1-S (AZD1222) vaccine compared with mRNA vaccines in haematopoi

接受异基因干细胞移植治疗髓系恶性肿瘤的患者对 COVID-19 mRNA 疫苗的特异性免疫应答受到免疫抑制治疗的改变

Specific immune response to mRNA vaccines against COVID-19 in patients receiving allogeneic stem cell transplantation for myeloid malignancy was alter

结果显示，HSCT 受者对 SARS-CoV-2 疫苗的体液和细胞适应性免疫应答均受到皮质类固醇治疗的显著抑制。对疫苗的特异性应答受到 HSCT 与接种疫苗之间间隔时间的显著影响。HSCT 后最早 5 个月接种疫苗即可产生良好应答。对疫苗的免疫应答与年龄、性别、HSC 供受者之间的 HLA 匹配或髓系恶性肿瘤类型无关。疫苗效力取决于 HSCT 后 6 个月时重建良好的 CD4 + T 细胞。

血液系统恶性肿瘤移植患者接种 SARS-CoV-2 BNT162b2 mRNA 疫苗后的抗体降低与固有细胞因子变化

Reduced Antibodies and Innate Cytokine Changes in SARS-CoV-2 BNT162b2 mRNA Vaccinated Transplant Patients With Hematological Malignancies.

mRNA BNT162b2 疫苗在五组免疫功能低下患者和健康对照中针对 SARS-CoV-2 的安全性和疗效：一项前瞻性开放标签临床试验

Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective

结果显示，mRNA BNT162b2 疫苗在免疫功能低下患者中是安全的。